PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
56.13
ESG score 80-90% of FBIO's 65.70. Walter Schloss would scrutinize governance quality and regulatory exposure.
51.62
Environmental score 90-95% of FBIO's 55.19. Bill Ackman would demand clear environmental improvement catalysts.
57.46
Social score 80-90% of FBIO's 64.75. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
59.31
Governance score below 80% of FBIO's 77.16. Jim Chanos would check for potential agency conflicts and oversight failures.